Cargando…
Corilagin: A Novel Antivirulence Strategy to Alleviate Streptococcus pneumoniae Infection by Diminishing Pneumolysin Oligomers
Pneumolysin (PLY) is a significant virulence factor of Streptococcus pneumoniae (S. pneumoniae), able to break through the defense system of a host and mediate the occurrence of a series of infections. Therefore, PLY as the most ideal target to prevent S. pneumoniae infection has received more and m...
Autores principales: | , , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9416474/ https://www.ncbi.nlm.nih.gov/pubmed/36014299 http://dx.doi.org/10.3390/molecules27165063 |
_version_ | 1784776489285189632 |
---|---|
author | Sheng, Qiushuang Hou, Xiaoning Wang, Nan Liu, Minda Zhu, Haoyu Deng, Xuming Liang, Xiaoying Chi, Gefu |
author_facet | Sheng, Qiushuang Hou, Xiaoning Wang, Nan Liu, Minda Zhu, Haoyu Deng, Xuming Liang, Xiaoying Chi, Gefu |
author_sort | Sheng, Qiushuang |
collection | PubMed |
description | Pneumolysin (PLY) is a significant virulence factor of Streptococcus pneumoniae (S. pneumoniae), able to break through the defense system of a host and mediate the occurrence of a series of infections. Therefore, PLY as the most ideal target to prevent S. pneumoniae infection has received more and more attention and research. Corilagin is a tannic acid that exhibits excellent inhibition of PLY oligomers without bacteriostatic activity to S. pneumoniae. Herein, hemolytic activity assays, cell viability tests and western blot experiments are executed to evaluate the antivirulence efficacy of corilagin against PLY in vitro. Colony observation, hematoxylin and eosin (H&E) staining and cytokines of bronchoalveolar lavage fluid (BALF) are applied to assess the therapeutic effect of corilagin in mice infected by S. pneumoniae. The results indicate the related genes of corilagin act mainly via enrichment in pathways associated with pneumonia disease. Furthermore, molecular docking and molecular dynamics simulations show that corilagin might bind with domains 3 and 4 of PLY and interfere with its hemolytic activity, which is further confirmed by the site-directed mutagenesis of PLY. Additionally, corilagin limits PLY oligomer production without impacting PLY expression in S. pneumoniae cultures. Moreover, corilagin effectively relieves PLY-mediated cell injury without any cytotoxicity, even then reducing the colony count in the lung and the levels of pro-inflammatory factors in BALF and remarkably improving lung lesions. All the results demonstrate that corilagin may be a novel strategy to cope with S. pneumoniae infection by inhibiting PLY oligomerization. |
format | Online Article Text |
id | pubmed-9416474 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2022 |
publisher | MDPI |
record_format | MEDLINE/PubMed |
spelling | pubmed-94164742022-08-27 Corilagin: A Novel Antivirulence Strategy to Alleviate Streptococcus pneumoniae Infection by Diminishing Pneumolysin Oligomers Sheng, Qiushuang Hou, Xiaoning Wang, Nan Liu, Minda Zhu, Haoyu Deng, Xuming Liang, Xiaoying Chi, Gefu Molecules Article Pneumolysin (PLY) is a significant virulence factor of Streptococcus pneumoniae (S. pneumoniae), able to break through the defense system of a host and mediate the occurrence of a series of infections. Therefore, PLY as the most ideal target to prevent S. pneumoniae infection has received more and more attention and research. Corilagin is a tannic acid that exhibits excellent inhibition of PLY oligomers without bacteriostatic activity to S. pneumoniae. Herein, hemolytic activity assays, cell viability tests and western blot experiments are executed to evaluate the antivirulence efficacy of corilagin against PLY in vitro. Colony observation, hematoxylin and eosin (H&E) staining and cytokines of bronchoalveolar lavage fluid (BALF) are applied to assess the therapeutic effect of corilagin in mice infected by S. pneumoniae. The results indicate the related genes of corilagin act mainly via enrichment in pathways associated with pneumonia disease. Furthermore, molecular docking and molecular dynamics simulations show that corilagin might bind with domains 3 and 4 of PLY and interfere with its hemolytic activity, which is further confirmed by the site-directed mutagenesis of PLY. Additionally, corilagin limits PLY oligomer production without impacting PLY expression in S. pneumoniae cultures. Moreover, corilagin effectively relieves PLY-mediated cell injury without any cytotoxicity, even then reducing the colony count in the lung and the levels of pro-inflammatory factors in BALF and remarkably improving lung lesions. All the results demonstrate that corilagin may be a novel strategy to cope with S. pneumoniae infection by inhibiting PLY oligomerization. MDPI 2022-08-09 /pmc/articles/PMC9416474/ /pubmed/36014299 http://dx.doi.org/10.3390/molecules27165063 Text en © 2022 by the authors. https://creativecommons.org/licenses/by/4.0/Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (https://creativecommons.org/licenses/by/4.0/). |
spellingShingle | Article Sheng, Qiushuang Hou, Xiaoning Wang, Nan Liu, Minda Zhu, Haoyu Deng, Xuming Liang, Xiaoying Chi, Gefu Corilagin: A Novel Antivirulence Strategy to Alleviate Streptococcus pneumoniae Infection by Diminishing Pneumolysin Oligomers |
title | Corilagin: A Novel Antivirulence Strategy to Alleviate Streptococcus pneumoniae Infection by Diminishing Pneumolysin Oligomers |
title_full | Corilagin: A Novel Antivirulence Strategy to Alleviate Streptococcus pneumoniae Infection by Diminishing Pneumolysin Oligomers |
title_fullStr | Corilagin: A Novel Antivirulence Strategy to Alleviate Streptococcus pneumoniae Infection by Diminishing Pneumolysin Oligomers |
title_full_unstemmed | Corilagin: A Novel Antivirulence Strategy to Alleviate Streptococcus pneumoniae Infection by Diminishing Pneumolysin Oligomers |
title_short | Corilagin: A Novel Antivirulence Strategy to Alleviate Streptococcus pneumoniae Infection by Diminishing Pneumolysin Oligomers |
title_sort | corilagin: a novel antivirulence strategy to alleviate streptococcus pneumoniae infection by diminishing pneumolysin oligomers |
topic | Article |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9416474/ https://www.ncbi.nlm.nih.gov/pubmed/36014299 http://dx.doi.org/10.3390/molecules27165063 |
work_keys_str_mv | AT shengqiushuang corilaginanovelantivirulencestrategytoalleviatestreptococcuspneumoniaeinfectionbydiminishingpneumolysinoligomers AT houxiaoning corilaginanovelantivirulencestrategytoalleviatestreptococcuspneumoniaeinfectionbydiminishingpneumolysinoligomers AT wangnan corilaginanovelantivirulencestrategytoalleviatestreptococcuspneumoniaeinfectionbydiminishingpneumolysinoligomers AT liuminda corilaginanovelantivirulencestrategytoalleviatestreptococcuspneumoniaeinfectionbydiminishingpneumolysinoligomers AT zhuhaoyu corilaginanovelantivirulencestrategytoalleviatestreptococcuspneumoniaeinfectionbydiminishingpneumolysinoligomers AT dengxuming corilaginanovelantivirulencestrategytoalleviatestreptococcuspneumoniaeinfectionbydiminishingpneumolysinoligomers AT liangxiaoying corilaginanovelantivirulencestrategytoalleviatestreptococcuspneumoniaeinfectionbydiminishingpneumolysinoligomers AT chigefu corilaginanovelantivirulencestrategytoalleviatestreptococcuspneumoniaeinfectionbydiminishingpneumolysinoligomers |